Epidemiological characteristics of rheumatoid arthritis in Japan: Prevalence estimates using a nationwide population-based questionnaire survey

References

• Taylor PC, Moore A, Vasilescu R, Alvir J, Tarallo M. A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective. Rheumatol Int. 2016;36(5):685–95.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75(1):3–15.
   PubMed Web of Science ®Google Scholar
• Boots AM, Maier AB, Stinissen P, Masson P, Lories RJ, De Keyser F. The influence of ageing on the development and management of rheumatoid arthritis. Nat Rev Rheumatol. 2013;9(10):604–13.
   PubMed Web of Science ®Google Scholar
• Kato H, Duff IF, Russell WJ, Uda Y, Hamilton HB, Kawamoto S, et al. Rheumatoid arthritis and gout in Hiroshima and Nagasaki, Japan. A prevalence and incidence study. J Chronic Dis. 1971;23(9):659–79.
   PubMedGoogle Scholar
• Shichikawa K, Inoue K, Hirota S, Maeda A, Ota H, Kimura M, et al. Changes in the incidence and prevalence of rheumatoid arthritis in Kamitonda, Wakayama, Japan, 1965–1996. Ann Rheum Dis. 1999;58(12):751–6.
   PubMed Web of Science ®Google Scholar
• Wood JW, Kato H, Johnson KG, Uda Y, Russell WJ, Duff IF. Rheumatoid arthritis in Hiroshima and Nagasaki, Japan. Prevalence, incidence, and clinical characteristics. Arthritis Rheum. 1967;10(1):21–31.
   PubMedGoogle Scholar
• Yamanaka H, Sugiyama N, Inoue E, Taniguchi A, Momohara S. Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I). Mod Rheumatol. 2014;24(1):33–40.
   PubMed Web of Science ®Google Scholar
• Eriksson JK, Neovius M, Ernestam S, Lindblad S, Simard JF, Askling J. Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration. Arthritis Care Res (Hoboken). 2013;65(6):870–8.
   PubMed Web of Science ®Google Scholar
• Rossini M, Rossi E, Bernardi D, Viapiana O, Gatti D, Idolazzi L, et al. Prevalence and incidence of rheumatoid arthritis in Italy. Rheumatol Int. 2014;34(5):659–64.
   PubMed Web of Science ®Google Scholar
• Crane MM, Juneja M, Allen J, Kurrasch RH, Chu ME, Quattrocchi E, et al. Epidemiology and treatment of new-onset and established rheumatoid arthritis in an insured US population. Arthritis Care Res (Hoboken). 2015;67(12):1646–55.
   PubMed Web of Science ®Google Scholar
• Jean S, Hudson M, Gamache P, Bessette L, Fortin PR, Boire G, et al. Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study. Clin Rheumatol. 2017;36(12):2667–71.
   PubMed Web of Science ®Google Scholar
• Kato E, Sawada T, Tahara K, Hayashi H, Tago M, Mori H, et al. The age at onset of rheumatoid arthritis is increasing in Japan: a nationwide database study. Int J Rheum Dis. 2017;20(7):839–45.
   PubMed Web of Science ®Google Scholar
• Statistics and Information Department. Minister's Secretariat. Ministry of Health Labour and Welfare of Japan. Comprehensive Survey of Living Conditions of the People on Health and Welfare; 2017. Available from: www.mhlw.go.jp/english/database/db-hss/cslc-index.html.
   Google Scholar
• Statistics Bureau. Ministry of Internal Affairs and Communications. Population estimates/2016/Annual Report; 2017. Available from: http://www.stat.go.jp/english/data/jinsui/index.html.
   Google Scholar
• Kessler RC, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand SL, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32(6):959–76.
   PubMed Web of Science ®Google Scholar
• Sakurai K, Nishi A, Kondo K, Yanagida K, Kawakami N. Screening performance of K6/K10 and other screening instruments for mood and anxiety disorders in Japan. Psychiatry Clin Neurosci. 2011;65(5):434–41.
   PubMed Web of Science ®Google Scholar
• Gayet-Ageron A, Agoritsas T, Schiesari L, Kolly V, Perneger TV. Barriers to participation in a patient satisfaction survey: who are we missing? PLoS One. 2011;6(10):e26852.
   PubMed Web of Science ®Google Scholar
• Statistics and Information Department. Minister's Secretariat. Ministry of Health Labour and Welfare of Japan. The patient survey. Available from: www.mhlw.go.jp/english/database/db-hss/ps.html.
   Google Scholar
• Kubo S, Noda T, Kawado M, Yamada H, Naka Mieno M, Tanihara S, et al. Changes in the average interval since last visit and the number of repeat outpatients in the Patient Survey of Japan. [Nihon Koshu Eisei Zasshi] Japan J Public Health. 2017;64(10):619–29.
   PubMedGoogle Scholar
• The Japan Rheumatism Friendship Association. 2015 white paper; the facts of patients with rheumatoid arthritis. Nagare. 2015;314:21–48.
   Google Scholar
• Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1316–22.
   PubMed Web of Science ®Google Scholar
• Kaipiainen-Seppanen O, Aho K, Isomaki H, Laakso M. Shift in the incidence of rheumatoid arthritis toward elderly patients in Finland during 1975–1990. Clin Exp Rheumatol. 1996;14(5):537–42.
   PubMed Web of Science ®Google Scholar
• Giles JT, Ling SM, Ferrucci L, Bartlett SJ, Andersen RE, Towns M, et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum. 2008;59(6):807–15.
   PubMed Web of Science ®Google Scholar
• Santilli V, Bernetti A, Mangone M, Paoloni M. Clinical definition of sarcopenia. Clin Cases Miner Bone Metabol. 2014;11(3):177–80.
   PubMedGoogle Scholar
• Targowski T. Sarcopaenia and rheumatoid arthritis. Reumatologia. 2017;55(2):84–7.
   PubMedGoogle Scholar
• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–23.
   PubMed Web of Science ®Google Scholar
• Almoallim H, Kamil A. Rheumatoid arthritis: should we shift the focus from “Treat to Target” to “Treat to Work?” Clin Rheumatol. 2013;32(3):285–7.
   PubMed Web of Science ®Google Scholar
• Williams M, Chakravarty EF. Rheumatoid arthritis and pregnancy: impediments to optimal management of both biologic use before, during and after pregnancy. Curr Opin Rheumatol. 2014;26(3):341–6.
   PubMed Web of Science ®Google Scholar
• Murray KE, Moore L, O’Brien C, Clohessy A, Brophy C, Minnock P, et al. Updated pharmacological management of rheumatoid arthritis for women before, during, and after pregnancy, reflecting recent guidelines. Ir J Med Sci. 2019;188(1):169–72.
   PubMed Web of Science ®Google Scholar
• Ponticelli C, Moroni G. Fetal toxicity of immunosuppressive drugs in pregnancy. J Clin Med. 2018;7(12):552.
   Web of Science ®Google Scholar